Recommendations for Planning Pilot Studies in Clinical and Translational Research

被引:444
作者
Moore, Charity G. [1 ]
Carter, Rickey E. [2 ]
Nietert, Paul J. [3 ]
Stewart, Paul W. [4 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[2] Mayo Clin, Rochester, MN USA
[3] Med Univ S Carolina, Charleston, SC 29425 USA
[4] Univ N Carolina, Chapel Hill, NC USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2011年 / 4卷 / 05期
基金
美国国家卫生研究院;
关键词
pilot studies; pilot study design; sample size; power calculations; confidence intervals; SAMPLE-SIZE; IMPORTANT DIFFERENCE; NURSING-RESEARCH; CRITICAL-CARE; TRIALS; DESIGN; CANCER; WORK;
D O I
10.1111/j.1752-8062.2011.00347.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Advances in clinical and translation science are facilitated by building on prior knowledge gained through experimentation and observation. In the context of drug development, preclinical studies are followed by a progression of phase I through phase IV clinical trials. At each step, the study design and statistical strategies are framed around research questions that are prerequisites for the next phase. In other types of biomedical research, pilot studies are used for gathering preliminary support for the next research step. However, the phrase "pilot study" is liberally applied to projects with little or no funding, characteristic of studies with poorly developed research proposals, and usually conducted with no detailed thought of the subsequent study. In this article, we present a rigorous definition of a pilot study, offer recommendations for the design, analysis and sample size justification of pilot studies in clinical and translational research, and emphasize the important role that well-designed pilot studies play in the advancement of science and scientific careers. Clin Trans Sci 2011; Volume 4: 332-337
引用
收藏
页码:332 / 337
页数:6
相关论文
共 26 条
[1]  
[Anonymous], 2002, Statistical Rules of Thumb
[2]   The design and interpretation of pilot trials in clinical research in critical care [J].
Arnold, Donald M. ;
Burns, Karen E. A. ;
Adhikari, Neill K. J. ;
Kho, Michelle E. ;
Meade, Maureen O. ;
Cook, Deborah J. .
CRITICAL CARE MEDICINE, 2009, 37 (01) :S69-S74
[3]   Current sample size conventions: Flaws, harms, and alternatives [J].
Bacchetti, Peter .
BMC MEDICINE, 2010, 8
[4]   ON THE USE OF A PILOT SAMPLE FOR SAMPLE-SIZE DETERMINATION [J].
BROWNE, RH .
STATISTICS IN MEDICINE, 1995, 14 (17) :1933-1940
[5]   Application of stochastic processes to participant recruitment in clinical trials [J].
Carter, RE .
CONTROLLED CLINICAL TRIALS, 2004, 25 (05) :429-436
[6]  
CARTER RE, 2007, ADV STAT METHODS HLT, V40, P540
[7]   Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside [J].
Carter R.E. ;
Woolson R.F. .
Journal of Translational Medicine, 2 (1)
[8]   Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies [J].
Chuang-Stein, Christy ;
Beltangady, Mohan .
PHARMACEUTICAL STATISTICS, 2011, 10 (01) :3-7
[9]   Prophylaxis of Thromboembolism in Critical Care (PROTECT)Trial:: a pilot study [J].
Cook, DJ ;
Rocker, G ;
Meade, M ;
Guyatt, G ;
Geerts, W ;
Anderson, D ;
Skrobik, Y ;
Hebert, P ;
Albert, M ;
Cooper, J ;
Bates, S ;
Caco, C ;
Finfer, S ;
Fowler, R ;
Freitag, A ;
Granton, J ;
Jones, G ;
Langevin, S ;
Mehta, S ;
Pagliarello, G ;
Poirier, G ;
Rabbat, C ;
Schiff, D ;
Griffith, L ;
Crowther, M .
JOURNAL OF CRITICAL CARE, 2005, 20 (04) :364-372
[10]   Understanding the minimum clinically important difference: a review of concepts and methods [J].
Copay, Anne G. ;
Subach, Brian R. ;
Glassman, Steven D. ;
Polly, David W., Jr. ;
Schuler, Thomas C. .
SPINE JOURNAL, 2007, 7 (05) :541-546